Market Overview

MEDNAX Appoints Stephen D. Farber as Executive Vice President, to Succeed Chief Financial Officer


MEDNAX, Inc. (NYSE:MD) (the "Company"), today announced the appointment
of Stephen D. Farber as Executive Vice President, effective August 27,
2018. The Company anticipates that Mr. Farber will assume the additional
role of Chief Financial Officer in November 2018, following the
Company's release of its operating results for the period ending
September 30, 2018, to succeed Vivian Lopez-Blanco, who recently
announced her planned retirement from the Company.

"We are very pleased to have Stephen join our team at MEDNAX," said
Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. "His unique
background as a proven leader of multiple large healthcare enterprises
makes him an outstanding addition to our Company. Stephen's depth of
knowledge and broad experience will serve us and our shareholders well
as we continue the execution of our operating and strategic plans and
remain committed to our mission of taking great care of our patients."

Mr. Farber has 25 years of healthcare experience, including as a senior
leader and Chief Financial Officer of large, publicly-traded and private
healthcare enterprises. He most recently was Executive Vice President
and Chief Financial Officer of Kindred Healthcare, Inc., which was one
of the nation's largest providers of post-acute services with
approximately $6 billion in revenue and 85,000 employees, until its sale
in July 2018. Earlier in his career, Mr. Farber served as Chief
Financial Officer of Tenet Healthcare Corporation (NYSE:THC), which
during his tenure was the nation's second-largest investor-owned
healthcare services company.

Mr. Farber has extensive experience in corporate, operational and
financial strategy, and has successfully helped grow and transform
healthcare companies. In addition to his executive roles at Kindred and
Tenet, he has been involved in various private equity efforts, including
as a healthcare executive-in-residence with Warburg Pincus LLC, a global
investment firm with more than $45 billion under management. Mr. Farber
began his career as an investment banker with J.P. Morgan and Donaldson,
Lufkin & Jenrette, where he focused on healthcare mergers and
acquisitions and leveraged finance.


MEDNAX, Inc. is a national health solutions partner comprised of the
nation's leading providers of physician services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives, clinical research
and telemedicine to enhance patient outcomes and provide high-quality,
cost-effective care. The Company was founded in 1979, and today, through
its affiliated professional corporations, MEDNAX provides services
through a network of approximately 4,100 physicians in all 50 states and
Puerto Rico. In addition to its national physician network, MEDNAX
provides services to healthcare facilities and physicians in over 40
states through two complementary businesses, consisting of a management
services company and a consulting services company. Additional
information is available at

Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to MEDNAX's
objectives, plans and strategies, and all statements, other than
statements of historical facts, that address activities, events or
developments that we intend, expect, project, believe or anticipate will
or may occur in the future. These statements are often characterized by
terminology such as "believe", "hope", "may", "anticipate", "should",
"intend", "plan", "will", "expect", "estimate", "project", "positioned",
"strategy" and similar expressions, and are based on assumptions and
assessments made by MEDNAX's management in light of their experience and
their perception of historical trends, current conditions, expected
future developments and other factors they believe to be appropriate.
Any forward-looking statements in this press release are made as of the
date hereof, and MEDNAX undertakes no duty to update or revise any such
statements, whether as a result of new information, future events or
otherwise. Forward-looking statements are not guarantees of future
performance and are subject to risks and uncertainties. Important
factors that could cause actual results, developments, and business
decisions to differ materially from forward-looking statements are
described in MEDNAX's most recent Annual Report on Form 10-K and its
Quarterly Reports on Form 10-Q, including the sections entitled "Risk
Factors", as well MEDNAX's current reports on Form 8-K, filed with the
Securities and Exchange Commission

View Comments and Join the Discussion!